About Boston Medical Sciences
Boston Medical Sciences is a company based in Chuo-ku (Japan) founded in 2023.. Boston Medical Sciences has raised $8.79 million across 3 funding rounds from investors including Beyond Next Ventures, EUCALIA and JIC Venture Growth Investments. Boston Medical Sciences operates in a competitive market with competitors including Panakeia, Nevia Bio, SquareMind, Onkolyze and GynEye, among others.
- Headquarter Chuo-ku, Japan
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$8.79 M (USD)
in 3 rounds
-
Latest Funding Round
$6.11 M (USD), Series A
Feb 12, 2025
-
Investors
Beyond Next Ventures
& 8 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Boston Medical Sciences
Boston Medical Sciences has successfully raised a total of $8.79M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $6.11 million completed in February 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series A — $6.1M
-
First Round
First Round
(05 Oct 2023)
- Investors Count 9
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2025 | Amount | Series A - Boston Medical Sciences | Valuation |
investors |
|
| Oct, 2024 | Amount | Seed - Boston Medical Sciences | Valuation |
investors |
|
| Oct, 2023 | Amount | Seed - Boston Medical Sciences | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Boston Medical Sciences
Boston Medical Sciences has secured backing from 9 investors, including venture fund and institutional investors. Prominent investors backing the company include Beyond Next Ventures, EUCALIA and JIC Venture Growth Investments. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Deep-tech investments and incubation services are provided for researchers and entrepreneurs addressing global challenges.
|
Founded Year | Domain | Location | |
|
Venture capital fund focused on growth stage companies
|
Founded Year | Domain | Location | |
|
Global Brain is recognized as a venture capital firm supporting startups.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Boston Medical Sciences
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Boston Medical Sciences
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Boston Medical Sciences Comparisons
Competitors of Boston Medical Sciences
Boston Medical Sciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Panakeia, Nevia Bio, SquareMind, Onkolyze and GynEye, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
AI-based software is provided for cancer diagnosis and precision treatment.
|
|
| domain | founded_year | HQ Location |
Machine learning-enabled platform for early detection of women-related diseases
|
|
| domain | founded_year | HQ Location |
Developer of robotic medical equipment for skin cancer detection
|
|
| domain | founded_year | HQ Location |
Ultrasound images are analyzed by AI platform for cancer detection.
|
|
| domain | founded_year | HQ Location |
Portable digital device for cervical exams, risk assessment, and telemedicine integration.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Boston Medical Sciences
Frequently Asked Questions about Boston Medical Sciences
When was Boston Medical Sciences founded?
Boston Medical Sciences was founded in 2023.
Where is Boston Medical Sciences located?
Boston Medical Sciences is headquartered in Chuo-ku, Japan. It is registered at Chuo-ku, Tokyo, Japan.
Who is the current CEO of Boston Medical Sciences?
Masaki Okamoto is the current CEO of Boston Medical Sciences.
Is Boston Medical Sciences a funded company?
Boston Medical Sciences is a funded company, having raised a total of $8.79M across 3 funding rounds to date. The company's 1st funding round was a Seed of $2.68M, raised on Oct 05, 2023.
What does Boston Medical Sciences do?
AI-powered colorectal cancer screening system. The company offers colorectal cancer screening virtual endoscopy system enabling healthcare providers to detect and treat colorectal cancer in its early stages.
Who are the top competitors of Boston Medical Sciences?
Boston Medical Sciences's top competitors include Inocras, Panakeia and Spotitearly.
Who are Boston Medical Sciences's investors?
Boston Medical Sciences has 9 investors. Key investors include Beyond Next Ventures, EUCALIA, JIC Venture Growth Investments, Global Brain, and Mitsubishi UFJ Capital.